You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
|
|---|---|
| Published in |
Journal of Translational Medicine, January 2014
|
| DOI | 10.1186/1479-5876-12-32 |
| Pubmed ID | |
| Authors |
Alpha A Fowler, Aamer A Syed, Shelley Knowlson, Robin Sculthorpe, Don Farthing, Christine DeWilde, Christine A Farthing, Terri L Larus, Erika Martin, Donald F Brophy, Seema Gupta, Medical Respiratory Intensive Care Unit Nursing, Bernard J Fisher, Ramesh Natarajan |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 29% |
| Australia | 2 | 5% |
| Canada | 2 | 5% |
| Poland | 1 | 2% |
| Spain | 1 | 2% |
| United Kingdom | 1 | 2% |
| Netherlands | 1 | 2% |
| Unknown | 22 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 34 | 81% |
| Practitioners (doctors, other healthcare professionals) | 6 | 14% |
| Scientists | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 414 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 412 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 63 | 15% |
| Other | 51 | 12% |
| Student > Master | 41 | 10% |
| Student > Bachelor | 30 | 7% |
| Student > Ph. D. Student | 27 | 7% |
| Other | 89 | 21% |
| Unknown | 113 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 180 | 43% |
| Nursing and Health Professions | 19 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 5% |
| Agricultural and Biological Sciences | 17 | 4% |
| Biochemistry, Genetics and Molecular Biology | 14 | 3% |
| Other | 39 | 9% |
| Unknown | 126 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 228. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2024.
All research outputs
#170,408
of 25,837,817 outputs
Outputs from Journal of Translational Medicine
#41
of 4,712 outputs
Outputs of similar age
#1,500
of 328,548 outputs
Outputs of similar age from Journal of Translational Medicine
#1
of 73 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,712 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.